Classical Mathematical Models for Description and Prediction of Experimental Tumor Growth

Abstract

Despite internal complexity, tumor growth kinetics follow relatively simple laws that can be expressed as mathematical models. To explore this further, quantitative analysis of the most classical of these were performed. The models were assessed against data from two in vivo experimental systems: an ectopic syngeneic tumor (Lewis lung carcinoma) and an orthotopically xenografted human breast carcinoma. The goals were threefold: 1) to determine a statistical model for description of the measurement error, 2) to establish the descriptive power of each model, using several goodness-of-fit metrics and a study of parametric identifiability, and 3) to assess the models' ability to forecast future tumor growth. The models included in the study comprised the exponential, exponential-linear, power law, Gompertz, logistic, generalized logistic, von Bertalanffy and a model with dynamic carrying capacity. For the breast data, the dynamics were best captured by the Gompertz and exponential-linear models. The latter also exhibited the highest predictive power, with excellent prediction scores (≥80%) extending out as far as 12 days in the future. For the lung data, the Gompertz and power law models provided the most parsimonious and parametrically identifiable description. However, not one of the models was able to achieve a substantial prediction rate (≥70%) beyond the next day data point. In this context, adjunction of a priori information on the parameter distribution led to considerable improvement. For instance, forecast success rates went from 14.9% to 62.7% when using the power law model to predict the full future tumor growth curves, using just three data points. These results not only have important implications for biological theories of tumor growth and the use of mathematical modeling in preclinical anti-cancer drug investigations, but also may assist in defining how mathematical models could serve as potential prognostic tools in the clinic.

Full text

Its licence does not allow us to show the full text. Read it at PubMed Central:

References 73

1. 1.

   Talmadge JE, Singh RK, Fidler IJ, Raz A (2007 ) Murine models to evaluate novel and conventional therapeutic strategies for cancer. Am J Pathol 170: 793–804 Available: http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=1864878&tool=pmcentrez&rendertype=abstract. Accessed 24 January 2014.

   Not in our library10.2353/ajpath.2007.060929

2. 2.

   Ebos JML, Lee CR, Cruz-Munoz W, Bjarnason GA, Christensen JG, et al (2009 ) Accelerated metastasis after short-term treatment with a potent inhibitor of tumor angiogenesis. Cancer Cell 15: 232–239 Available: http://www.ncbi.nlm.nih.gov/pubmed/19249681. Accessed 14 July 2012.

   Not in our library10.1016/j.ccr.2009.01.021

3. 3.

   Collins VP, Loeffler RK, Tivey H (1956 ) Observations on growth rates of human tumors. Am J Roentgenol Radium Ther Nucl Med 76: 988–1000.

   Not in our library

4. 4.

   Steel GG (1977) Growth kinetics of tumours. Clarendon Press. Oxford.

   Not in our library

5. 5.

   Hart D, Shochat E, Agur Z (1998 ) The growth law of primary breast cancer as inferred from mammography screening trials data. Br J Cancer 78: 382–387 Available: http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=2063020&tool=pmcentrez&rendertype=abstract.

   Not in our library10.1038/bjc.1998.503

6. 6.

   Friberg S, Mattson S (1997 ) On the growth rates of human malignant tumors: implications for medical decision making. J Surg Oncol 284–297 Available: http://www.bioquest.org/summer2010/wp-content/blogs.dir/files/2010/02/Friberg1998.pdf. Accessed 22 January 2014.

   Not in our library10.1002/(sici)1096-9098(199708)65:4<284::aid-jso11>3.0.co;2-2

7. 7.

   Spratt JaS, Meyer JS (1996 ) Rates of growth of human neoplasms: part II. J Surg Oncol 61: 143–150 Available: http://www.ncbi.nlm.nih.gov/pubmed/8544465.

   Not in our library10.1002/1096-9098(199601)61:1<68::aid-jso2930610102>3.0.co;2-e

8. 8.

   Heuser L, Spratt JS, Polk HC (1979 ) Growth rates of primary breast cancers. Cancer 43: 1888–1894 Available: http://www.ncbi.nlm.nih.gov/pubmed/445375.

   Not in our library10.1002/1097-0142(197905)43:5<1888::aid-cncr2820430545>3.0.co;2-m

9. 9.
   Dynamics of Tumour Growth: Comparison of Growth Rates and Extrapolation of Growth Curve to One Cell · 1965

   No notice
10. 10.

    Steel GG, Lamerton LF (1966 ) The growth rate of human tumours. Br J Cancer 20: 74–86 Available: http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=2008056&tool=pmcentrez&rendertype=abstract.

    Not in our library10.1038/bjc.1966.9

11. 11.

    Spratt JA, von Fournier D, Spratt JS, Weber EE (1993 ) Decelerating growth and human breast cancer. Cancer 71: 2013–2019 Available: http://www.ncbi.nlm.nih.gov/pubmed/8443753.

    Not in our library10.1002/1097-0142(19930315)71:6<2013::aid-cncr2820710615>3.0.co;2-v

12. 12.

    Akanuma A (1978 ) Parameter analysis of Gompertzian function growth model in clinical tumors. Eur J Cancer 14: 681–688 Available: http://www.ncbi.nlm.nih.gov/pubmed/658092.

    Not in our library10.1016/0014-2964(78)90304-3

13. 13.

    Wheldon TE (1988 ) Mathematical models in cancer research. Hilger Bristol

    Not in our library

14. 14.

    Gerlee P (2013 ) The model muddle: in search of tumor growth laws. Cancer Res 73: 2407–2411 Available: http://www.ncbi.nlm.nih.gov/pubmed/23393201. Accessed 9 June 2013.

    Not in our library10.1158/0008-5472.can-12-4355

15. 15.

    Norton L, Simon R, Brereton HD, Bogden AE (1976 ) Predicting the course of Gompertzian growth. Nature 264: 542–544 Available: http://www.nature.com/nature/journal/v264/n5586/abs/264542a0.html. Accessed 6 January 2014.

    Not in our library10.1038/264542a0

16. 16.

    Colin T, Iollo A, Lombardi D, Saut O (2010 ) Prediction of the evolution of thyroidal lung nodules using a mathematical model. ERCIM News 37–38.

    Not in our library

17. 17.

    Ribba B, Kaloshi G, Peyre M, Ricard D, Calvez V, et al (2012 ) A tumor growth inhibition model for low-grade glioma treated with chemotherapy or radiotherapy. Clin Cancer Res 18: 5071–5080 Available: http://www.ncbi.nlm.nih.gov/pubmed/22761472. Accessed 11 March 2013.

    Not in our library10.1158/1078-0432.ccr-12-0084

18. 18.

    Baldock AL, Rockne RC, Boone AD, Neal ML, Hawkins-Daarud A, et al (2013 ) From patient-specific mathematical neuro-oncology to precision medicine. Front Oncol 3: 62 Available: http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3613895&tool=pmcentrez&rendertype=abstract. Accessed 31 May 2013.

    Not in our library10.3389/fonc.2013.00062

19. 19.

    Wang CH, Rockhill JK, Mrugala M, Peacock DL, Lai A, et al (2009 ) Prognostic significance of growth kinetics in newly diagnosed glioblastomas revealed by combining serial imaging with a novel biomathematical model. Cancer Res 69: 9133–9140 Available: http://www.ncbi.nlm.nih.gov/pubmed/19934335. Accessed 29 July 2012.

    Not in our library10.1158/0008-5472.can-08-3863

20. 20.

    Portz T, Kuang Y, Nagy JD (2012 ) A clinical data validated mathematical model of prostate cancer growth under intermittent androgen suppression therapy. AIP Adv 2: 011002 Available: http://link.aip.org/link/AAIDBI/v2/i1/p011002/s1&Agg=doi. Accessed 29 July 2013.

    Not in our library

21. 21.

    Bernard A, Kimko H, Mital D, Poggesi I (2012 ) Mathematical modeling of tumor growth and tumor growth inhibition in oncology drug development. Expert Opin Drug Metab Toxicol 8: 1057–1069 Available: http://www.ncbi.nlm.nih.gov/pubmed/22632710. Accessed 6 January 2014.

    Not in our library10.1517/17425255.2012.693480

22. 22.

    Simeoni M, De Nicolao G, Magni P, Rocchetti M, Poggesi I (2013 ) Modeling of human tumor xenografts and dose rationale in oncology. Drug Discov Today Technol 10: e365–72 Available: http://www.ncbi.nlm.nih.gov/pubmed/24050133. Accessed 3 January 2014.

    Not in our library10.1016/j.ddtec.2012.07.004

23. 23.

    Drasdo D, Höhme S (2005 ) A single-cell-based model of tumor growth in vitro: monolayers and spheroids. Phys Biol 2: 133–147.

    Not in our library10.1088/1478-3975/2/3/001

24. 24.

    Gao X, McDonald JT, Hlatky L, Enderling H (2013 ) Acute and fractionated irradiation differentially modulate glioma stem cell division kinetics. Cancer Res 73: 1481–1490 Available: http://www.ncbi.nlm.nih.gov/pubmed/23269274. Accessed 4 February 2013.

    Not in our library10.1158/0008-5472.can-12-3429

25. 25.

    Gatenby RA, Gawlinski ET (1996 ) A reaction-diffusion model of cancer invasion. Cancer Res 56: 5745–5753 Available: http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=2873430&tool=pmcentrez&rendertype=abstract.

    Not in our library

26. 26.

    Ambrosi D, Mollica F (2003) Mechanical models in tumour growth. In: Preziosi L, editor. Cancer Modelling and Simulation. CRC Press. pp. 142–166.

    Not in our library

27. 27.

    Bresch D, Colin T, Grenier E, Ribba B, Saut O (2010 ) Computational Modeling of Solid Tumor Growth: The Avascular Stage. SIAM J Sci Comput 32: 2321 Available: http://link.aip.org/link/SJOCE3/v32/i4/p2321/s1&Agg=doi.

    Not in our library

28. 28.

    Casey AE (1934 ) The experimental alteration of malignancy with an homologous mammalian tumor material: I. Results with intratesticular inoculation. Am J Cancer 21: 760–775.

    Not in our library

29. 29.
    Dynamics of Tumor Growth · 1964

    No notice
30. 30.

    Vaidya VG, Alexandro FJ (1982 ) Evaluation of some mathematical models for tumor growth. Int J Biomed Comput 13: 19–36 Available: http://www.ncbi.nlm.nih.gov/pubmed/7061168.

    Not in our library10.1016/0020-7101(82)90048-4

31. 31.

    Michelson S, Glicksman a S, Leith JT (1987 ) Growth in solid heterogeneous human colon adenocarcinomas: comparison of simple logistical models. Cell Tissue Kinet 20: 343–355 Available: http://www.ncbi.nlm.nih.gov/pubmed/3690626.

    Not in our library10.1111/j.1365-2184.1987.tb01316.x

32. 32.

    Norton L (1988 ) A Gompertzian model of human breast cancer growth. Cancer Res 48: 7067–7071 Available: http://cancerres.aacrjournals.org/content/48/24_Part_1/7067.short. Accessed 9 July 2013.

    Not in our library

33. 33.

    Marusić M, Bajzer Z, Freyer JP, Vuk-Pavlović S (1994 ) Analysis of growth of multicellular tumour spheroids by mathematical models. Cell Prolif 27: 73–94 Available: http://www.ncbi.nlm.nih.gov/pubmed/10465028.

    Not in our library10.1111/j.1365-2184.1994.tb01407.x

34. 34.

    Bertalanffy LVon (1957 ) Quantitative laws in metabolism and growth. Q Rev Biol 32: 217–231 Available: http://www.jstor.org/stable/10.2307/2815257. Accessed 21 January 2014.

    Not in our library10.1086/401873

35. 35.

    West GB, Brown JH, Enquist BJ (2001 ) A general model for ontogenetic growth. Nature 413: 628–631 Available: http://www.ncbi.nlm.nih.gov/pubmed/11675785.

    Not in our library10.1038/35098076

36. 36.

    Guiot C, Degiorgis PG, Delsanto PP, Gabriele P, Deisboeck TS (2003 ) Does tumor growth follow a “universal law”? J Theor Biol 225: 147–151 Available: http://linkinghub.elsevier.com/retrieve/pii/S0022519303002212. Accessed 29 July 2012.

    Not in our library10.1016/s0022-5193(03)00221-2

37. 37.

    Herman AB, Savage VM, West GB (2011 ) A quantitative theory of solid tumor growth, metabolic rate and vascularization. PLoS One 6: e22973 Available: http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3182997&tool=pmcentrez&rendertype=abstract. Accessed 23 March 2014.

    Not in our library10.1371/journal.pone.0022973

38. 38.

    Dethlefsen LA, Prewitt JM, Mendelsohn ML (1968 ) Analysis of tumor growth curves. J Natl Cancer Inst 40: 389–405 Available: http://www.ncbi.nlm.nih.gov/pubmed/5638610.

    Not in our library10.1093/jnci/40.2.389

39. 39.

    Simeoni M, Magni P, Cammia C, De Nicolao G, Croci V, et al (2004 ) Predictive pharmacokinetic-pharmacodynamic modeling of tumor growth kinetics in xenograft models after administration of anticancer agents. Cancer Res 64: 1094–1101 Available: http://cancerres.aacrjournals.org/cgi/doi/10.1158/0008-5472.CAN-03-2524. Accessed 30 July 2012.

    Not in our library10.1158/0008-5472.can-03-2524

40. 40.

    Wilson S, Grenier E, Wei M, Calvez V, You B, et al (2013 ) Modeling the synergism between the anti-angiogenic drug sunitinib and irinotecan in xenografted mice. PAGE 22: 2826.

    Not in our library

Cited by papers we hold 4

• Computational modeling and simulation of stenosis of the cerebral aqueduct due to brain tumor · 2022
  Not checked
• Model-based inference of metastatic seeding rates in de novo metastatic breast cancer reveals the impact of secondary seeding and molecular subtype · 2022
  Not checked
• Mathematical Models of Cancer: When to Predict Novel Therapies, and When Not to · 2019
  No notice
• The use of Gompertz models in growth analyses, and new Gompertz-model approach: An addition to the Unified-Richards family · 2017
  No notice

Reads

A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.